Literature DB >> 34542747

Role of H2S in Regulation of Vascular Tone in Metabolic Disorders.

Yu G Birulina1, V V Ivanov2, E E Buyko2, I O Gabitova2, I V Kovalev2, A V Nosarev2, L V Smagliy2, S V Gusakova2.   

Abstract

We studied the effect of the H2S donor (NaHS, 1-500 μM) on the contractile responses of isolated aortic smooth muscle segments from rats with metabolic syndrome induced by high-fat, high-carbohydrate diet. It was found that the vasorelaxing effect of NaHS (5-100 μM) decreased in under conditions of MS. The endothelial NO synthase inhibitor L-NAME (100 μM) suppressed the effect of NaHS, while cystathionine-gamma-lyase inhibitor PAG (100 μM) decreased the vasodilating effects of acetylcholine (0.1-100 μM). Application of endogenous NO precursor L-arginine (1 mM) potentiated in the effects of H2S donor NaHS. Thus, the contractile activity of vascular smooth muscles in metabolic syndrome is determined by not only the effect of H2S, but also the influence of NO.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  hydrogen sulfide; metabolic syndrome; nitric oxide; vascular smooth muscles

Mesh:

Substances:

Year:  2021        PMID: 34542747     DOI: 10.1007/s10517-021-05243-y

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  10 in total

Review 1.  Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications.

Authors:  Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

2.  Regulation of Vascular Smooth Muscle Contractions in the Model of Metabolic Syndrome.

Authors:  Yu G Birulina; V V Ivanov; E E Buyko; E P Efremkina; L V Smagliy; I V Kovalev; A V Nosarev; S V Gusakova
Journal:  Bull Exp Biol Med       Date:  2020-12-02       Impact factor: 0.804

3.  Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.

Authors:  Mariarosaria Bucci; Valentina Vellecco; Anna Cantalupo; Vincenzo Brancaleone; Zongmin Zhou; Stefano Evangelista; Vincenzo Calderone; Andreas Papapetropoulos; Giuseppe Cirino
Journal:  Cardiovasc Res       Date:  2014-02-05       Impact factor: 10.787

Review 4.  Hydrogen sulfide and the metabolic syndrome.

Authors:  Kaushik M Desai; Tuanjie Chang; Ashley Untereiner; Lingyun Wu
Journal:  Expert Rev Clin Pharmacol       Date:  2011-01       Impact factor: 5.045

Review 5.  Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives.

Authors:  A Martelli; L Testai; A Marino; M C Breschi; F Da Settimo; V Calderone
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Endothelium-dependent hyperpolarization-mediated vasodilatation compensates nitric oxide-mediated endothelial dysfunction during ischemia in diabetes-induced canine coronary collateral microcirculation in vivo.

Authors:  Toyotaka Yada; Hiroaki Shimokawa; Hiroyuki Tachibana
Journal:  Microcirculation       Date:  2018-05-18       Impact factor: 2.628

7.  Hydrogen sulfide potentiates the favorable metabolic effects of inorganic nitrite in type 2 diabetic rats.

Authors:  Sevda Gheibi; Sajad Jeddi; Mattias Carlström; Khosrow Kashfi; Asghar Ghasemi
Journal:  Nitric Oxide       Date:  2019-08-31       Impact factor: 4.427

Review 8.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

Review 9.  Hydrogen sulfide and vascular regulation - An update.

Authors:  Boyang Lv; Selena Chen; Chaoshu Tang; Hongfang Jin; Junbao Du; Yaqian Huang
Journal:  J Adv Res       Date:  2020-05-16       Impact factor: 10.479

Review 10.  Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches.

Authors:  Valentina Citi; Alma Martelli; Era Gorica; Simone Brogi; Lara Testai; Vincenzo Calderone
Journal:  J Adv Res       Date:  2020-05-19       Impact factor: 10.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.